PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Nov-2022 Evotec completes acquisition of Central Glass Germany Evotec SE
03-Nov-2022 Broad-acting antiviral SARS-CoV-2 drug FYB207 shows longer half-life and improved efficacy through optimized molecular design in preclinical studies Formycon AG
03-Nov-2022 AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million AEVIS VICTORIA SA
03-Nov-2022 STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 STRATEC SE
02-Nov-2022 MIMETAS Elected Most Innovative Company of the Netherlands B3C newswire
02-Nov-2022 CPHI Excellence in Pharma Award Winners 2022 CPHI Frankfurt
02-Nov-2022 MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result MediClin AG
02-Nov-2022 Evotec presents paradigm shift in biologics at Capital Markets Day Evotec SE
02-Nov-2022 Straumann Group reports 12% organic revenue growth in the third quarter of 2022 Straumann Holding AG
02-Nov-2022 Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules Kuros Biosciences AG
01-Nov-2022 New Management Team at Hemovent Hemovent GmbH
01-Nov-2022 Top Pharmaceutical and Life Science Events in November (2022) PharmiWeb.Jobs
01-Nov-2022 Jean-Frédéric Chibret, President of Laboratoires Théa, has received the Entrepreneur of the Year Award for 2022 Théa
01-Nov-2022 ACI Group inks exclusive UK nutraceutical distribution deal with two leading brands ACI Group
01-Nov-2022 Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company Norstella
01-Nov-2022 Increasing throughput for pharmaceutical laboratories Technobis Crystallization Systems
01-Nov-2022 BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting Sciad Newswire
01-Nov-2022 ProteoNic Announces Broadening of GigaGen’s Rights to 2G UNic™ Technology B3C newswire
01-Nov-2022 Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine Lonza Group AG
01-Nov-2022 ProcCluster® from portfolio company inflamed pharma granted US patent Xlife Sciences AG